EP2577267A1 - Vorrichtung und verfahren zur messung eines analyten wie etwa bilirubin anhand von licht - Google Patents

Vorrichtung und verfahren zur messung eines analyten wie etwa bilirubin anhand von licht

Info

Publication number
EP2577267A1
EP2577267A1 EP11722914.6A EP11722914A EP2577267A1 EP 2577267 A1 EP2577267 A1 EP 2577267A1 EP 11722914 A EP11722914 A EP 11722914A EP 2577267 A1 EP2577267 A1 EP 2577267A1
Authority
EP
European Patent Office
Prior art keywords
light
filter
subject
filters
narrow band
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP11722914.6A
Other languages
English (en)
French (fr)
Inventor
Eduard Johannes Meijer
Srinivas Rao Kudavelly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke Philips NV
Original Assignee
Koninklijke Philips Electronics NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Philips Electronics NV filed Critical Koninklijke Philips Electronics NV
Publication of EP2577267A1 publication Critical patent/EP2577267A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/47Scattering, i.e. diffuse reflection
    • G01N21/49Scattering, i.e. diffuse reflection within a body or fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/44Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441Skin evaluation, e.g. for skin disorder diagnosis
    • A61B5/443Evaluating skin constituents, e.g. elastin, melanin, water
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/255Details, e.g. use of specially adapted sources, lighting or optical systems
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/314Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
    • G01N2021/3144Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths for oxymetry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/314Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
    • G01N2021/3148Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths using three or more wavelengths
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/314Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
    • G01N2021/317Special constructive features
    • G01N2021/3177Use of spatially separated filters in simultaneous way
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/314Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
    • G01N2021/3181Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths using LEDs
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2201/00Features of devices classified in G01N21/00
    • G01N2201/06Illumination; Optics
    • G01N2201/062LED's
    • G01N2201/0627Use of several LED's for spectral resolution
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2201/00Features of devices classified in G01N21/00
    • G01N2201/08Optical fibres; light guides
    • G01N2201/0826Fibre array at source, distributing

Definitions

  • the present invention relates to the an apparatus and method for measuring an analyte, such as a tissue analyte like bilirubin, using light, and, in one particular embodiment relates to estimation of tissue analyte levels in individuals, such as neonates, and more specifically, to an apparatus and method of determining transcutaneous bilirubin (TcB) and estimating total serum bilirubin (TSB) based thereon.
  • an analyte such as a tissue analyte like bilirubin
  • TcB transcutaneous bilirubin
  • TSB total serum bilirubin
  • Neonatal jaundice is a yellowing of the skin and other tissues of a newborn infant.
  • a bilirubin level of more than 5 mg/dL manifests clinical jaundice in neonates.
  • Management of jaundiced neonates typically requires the measurement and monitoring of total serum bilirubin (TSB), which is most commonly determined by analyzing a plasma or serum sample from the infant.
  • TBS total serum bilirubin
  • the drawing of blood from infants for such an analysis causes pain and trauma. This fact has lead to the development of a number of non-invasive techniques for estimation of TSB.
  • TcB transcutaneous bilirubin
  • Transcutaneous Bilirubinometry devices work by directing light into the skin of the neonate and detecting specific wavelengths that are reflected back from the neonate's subcutaneous tissues. The number of wavelengths used varies among different devices. The detected optical signals are converted to electrical signals by a photodetector, such as a photodiode, and the electrical signals are analyzed by a controller to generate a TSB value based on the intensity of the reflected signals.
  • a white light source is combined with a spectrometer to make the needed measurements. While effective, this solution is more expensive than it needs to be since not all spectral bands are used in the analysis to determine TSB.
  • an analyte measuring device for monitoring, for example and without limitation, tissue analyte levels (e.g., bilirubin levels), that includes a number of narrow band light sources, each narrow band light source being structured to emit a spectrum of light covering a number of wavelengths, and a number of detector assemblies configured to receive light reflected from a subject (e.g., the transcutaneous tissues of the subject).
  • tissue analyte levels e.g., bilirubin levels
  • a subject e.g., the transcutaneous tissues of the subject
  • Each of the detector assemblies includes a filter and a photodetector, each filter being structured to transmit a main transmission band and one or more transmission sidebands, wherein for each narrow band light source the spectrum thereof includes one or more wavelengths that fall within the transmission band of at least one of the filters, and wherein for each narrow band light source the spectrum thereof does not include any wavelengths that fall within the one or more transmission sidebands of any of the optical filters.
  • a method of estimating level of an analyte such as a tissue analyte (e.g, bilirubin), of a subject, includes steps of directing light from a number of light sources toward the subject (e.g., toward the skin of the subject), each light source emitting a spectrum of light covering a number of wavelengths, wherein in response to the directing, reflected light is reflected by the subject (e.g., the transcutaneous tissues of the subject), filtering the reflected light using a number of filters, each filter being structured to transmit a main transmission band and one or more transmission sidebands, wherein for each light source the spectrum thereof includes one or more wavelengths that fall within the transmission band of at least one of the filters, and wherein for each light source the spectrum thereof does not include any wavelengths that fall within the one or more transmission sidebands of any of the filters, the filtering producing a filtered light associated with each filter, and determining an estimated analyte level, such as
  • FIG. 1 is a block diagram of a bilirubin measuring device according to an exemplary embodiment of the present invention
  • FIG. 2 is a graph of transmission versus wavelength for an exemplary optical filter that may be employed in the bilirubin measuring device of FIG. 1 ;
  • FIG. 3 is a graph of intensity versus wavelength for two narrow band light sources that may be used in a particular embodiment of the bilirubin measuring device of FIG. 1 ;
  • FIG. 4 is a graph of transmission versus wavelength for three optical filters that may be employed in a particular embodiment of the bilirubin measuring device of FIG. 1 ;
  • FIG. 5 shows the measured effective filter responses based on the filters of FIG. 4 illuminated by the light sources of FIG. 3.
  • number shall mean one or an integer greater than one (i.e., a plurality).
  • the present invention relates the measurement of analytes, such as, without limitation, tissue analytes like bilirubin, using light analysis, and in particular to an apparatus and method for measuring such analytes.
  • tissue analyte is bilirubin.
  • the present invention is described in connection with a device for monitoring bilirubin that is able to estimate bilirubin levels using Transcutaneous Bilirubinometry.
  • tissue analytes such as, without limitation, oxygen saturation (SpCh), VO2, melanin, and hemoglobin and hemoglobin components like methemoglobin, oxyhemoglobin, deoxyhemoglobin, carboxyhemoglobin, etc., or other non-tissues analytes such as color pigment.
  • SpCh oxygen saturation
  • VO2 VO2
  • melanin melanin
  • hemoglobin and hemoglobin components like methemoglobin, oxyhemoglobin, deoxyhemoglobin, carboxyhemoglobin, etc.
  • other non-tissues analytes such as color pigment.
  • FIG. 1 is a block diagram of bilirubin measuring device 5 according to an exemplary embodiment of the present invention.
  • Bilirubin measuring device 5 includes a number of narrow band light sources 10, which in the illustrated embodiment are narrow band light source 10A and narrow band light source 10B (while two such narrow band light sources 10 are shown, that is meant to be exemplary only and it will be appreciated that more or less than two narrow band light sources 10 may also be used).
  • Each narrow band light source 10A, 10B emits light in a separate transmission band region comprising a selected, limited range of wavelengths.
  • Each narrow band light source 10A, 10B is thus not a white light source.
  • Each narrow band light source 10A, 10B may be, for example and without limitation, an LED centered at a particular peak wavelength.
  • Narrow band light sources 10A, 10B are structured and configured within bilirubin measuring device 5 to transmit light toward the skin of an individual, such as a neonate.
  • one or more optical fibers coupled to narrow band light sources 10A, 10B may be used to direct the light toward the skin of the subject.
  • Bilirubin measuring device 5 further includes a number of detector assemblies 15, which in the illustrated embodiment are detector assemblies 15A, 15B, 15C (while three such detector assemblies 15 are shown, that is meant to be exemplary only and it will be appreciated that more or less than thee detector assemblies 15 may also be used).
  • Detector assemblies 15A, 15B, 15C are each structured to receive and detect light reflected from the subcutaneous tissue of an individual, such as a neonate.
  • one or more optical fibers may be coupled to each of the detector assemblies 15A, 15B, 15C to collect and direct the reflected light toward the detector assembly 15A, 15B, 15C.
  • Each detector assembly 15A, 15B, 15C is, in the exemplary embodiment, shielded from all light except the light from the narrow band light sources 1 OA, 1 OB that is reflected.
  • Each detector assembly 15A, 15B, 15C includes an optical filter 20A, 20B, 20C operatively coupled to (e.g., positioned on top of) an associated photodetector 25A, 25B, 25C.
  • Each photodetector 25A, 25B, 25C is a device, such as, without limitation, a photodiode, that converts light into a current or voltage.
  • each optical filter 20A, 20B, 20C is a band pass filter that is centered at a predetermined wavelength of light with a predetermined full-width at half maximum (FWHM).
  • each optical filter 20A, 20B, 20C is a filter that transmits a main transmission band and one or more transmission sidebands, such as, without limitation, an all-dielectric interference filter stack employing, for example, quarter wavelength mirrors.
  • the transmission characteristics of such a filter are shown in FIG. 2, which illustrates a filter having a transmission band centered at 517 nm (with a FWHM of 5 nm) and at least two sidebands. All- dielectric interference filter stacks are advantageous because they have high transmission, good selectivity, and are relatively easy to fabricate on an industrial scale. In an exemplary embodiment, none of the transmission bands overlap one another.
  • each narrow band light source 1 OA, 10B emits a spectrum of light that includes light of the center wavelength of one or more of the optical filters 20A, 20B, 20C.
  • the emission spectrum of each narrow band light source 1 OA, 10B does not include any light that falls within the transmission sidebands of any of the optical filters 20A, 20B, 20C.
  • narrow band light source 10A is a cyan LED centered at about 485 nm and narrow band light source 10B is a green LED centered at about 530 nm.
  • the emission characteristics of these light sources are shown in FIG. 3.
  • optical filter 20A is an all-dielectric interference filter stack that is centered at 484.22 nm with a FWHM of 5.60714 nm
  • optical filter 20B is an all-dielectric interference filter stack that is centered at 517.61 nm with a FWHM of 6.74956 nm
  • optical filter 20C is an all- dielectric interference filter stack that is centered at 564.19 nm with a FWHM of 7.35165 nm.
  • FIG. 4 shows the measured effective filter responses based on the filters of FIG. 4 illuminated by the light sources of FIG. 3.
  • bilirubin measuring device 5 also includes controller 30 that is operatively coupled to narrow band light sources 10A, 10B and detector assemblies 15A, 15B, 15C.
  • Controller 30 includes a processing portion which may be, for example, a microprocessor, a microcontroller or some other suitable processing device, and a memory portion that may internal to the processing portion or operatively coupled to the processing portion and that provides a storage medium for data and software executable by the processing portion for controlling the operation of bilirubin measuring device 5, including calculating TcB and/or estimating TSB based on the intensity levels of the light detected by detector assemblies 15A, 15B, 15C.
  • bilirubin measuring device 5 is placed against the skin of a subject, such as a neonate. Controller 30 then causes narrow band light sources 10A, 10B to emit and direct light toward the skin of the subject. Light that is reflected from the subcutaneous tissues is filtered by the optical filters 20A, 20B, 20C and detected by the photodetectors 25A, 25B, 25C, which each convert the detected light into an electrical signal (voltage or current). Those electrical signals are then provided to controller 30. Controller 30 will then calculate TcB and/or estimate TSB based on those signals using any of a number of known methodologies. Suitable methodologies are described in, for example, one or more of the following, the disclosures of which are incorporated herein by reference: United States Patent Nos.
  • bilirubin measuring device 5 is a fully integrated system, where both narrow band light sources 1 OA, 10B and detector assemblies 15A, 15B, 15C are positioned on the same measurement board, positioned slightly apart from the skin or measurement surface, to allow the light emitted by the narrow band light sources 1 OA, 10B to reflect back from that surface and back-reflect to the detector assemblies 15A, 15B, 15C. Care should be taken to prevent direct light from the narrow band light sources 10A, 10B from hitting the detector assemblies 15A, 15B, 15C. Rather, only reflected light should be permitted to do so.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Optics & Photonics (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP11722914.6A 2010-05-27 2011-04-27 Vorrichtung und verfahren zur messung eines analyten wie etwa bilirubin anhand von licht Withdrawn EP2577267A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34888010P 2010-05-27 2010-05-27
PCT/IB2011/051856 WO2011148280A1 (en) 2010-05-27 2011-04-27 Apparatus and method for measuring an analyte such as bilirubin, using light

Publications (1)

Publication Number Publication Date
EP2577267A1 true EP2577267A1 (de) 2013-04-10

Family

ID=44120323

Family Applications (1)

Application Number Title Priority Date Filing Date
EP11722914.6A Withdrawn EP2577267A1 (de) 2010-05-27 2011-04-27 Vorrichtung und verfahren zur messung eines analyten wie etwa bilirubin anhand von licht

Country Status (4)

Country Link
US (1) US9279763B2 (de)
EP (1) EP2577267A1 (de)
CN (1) CN102906559B (de)
WO (1) WO2011148280A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140090506A (ko) * 2013-01-09 2014-07-17 삼성전자주식회사 검사장치 및 이를 이용한 검체 측정방법
KR101403507B1 (ko) 2013-03-21 2014-06-09 주식회사 현일바이오 결핵균 및 비결핵 마이코박테리아의 선택적 검출 방법, 그리고 이를 이용한 키트
WO2015018657A1 (en) 2013-08-06 2015-02-12 Koninklijke Philips N.V. System and method for extracting physiological information from remotely detected electromagnetic radiation
CN103454254A (zh) * 2013-09-09 2013-12-18 中国科学院苏州生物医学工程技术研究所 一种spr仪探测单元
JP6340084B2 (ja) 2014-03-21 2018-06-06 ハイパーメツド・イメージング・インコーポレイテツド 小型光センサ
US9655519B2 (en) 2014-03-21 2017-05-23 Hypermed Imaging, Inc. Systems and methods for performing an imaging test under constrained conditions
EP3125760B1 (de) * 2014-04-02 2020-12-30 BiliBaby, LLC System und verfahren zur bestimmung der bilirubinspiegel bei neugeborenen
WO2017201093A1 (en) 2016-05-17 2017-11-23 Hypermed Imaging, Inc. Hyperspectral imager coupled with indicator molecule tracking
CN106214126B (zh) * 2016-07-22 2019-03-29 王玉钟 一种胆红素的检测装置及检测方法
CN112525854A (zh) * 2019-09-18 2021-03-19 大连兆晶生物科技有限公司 一种鉴定成分的方法
CN112525853A (zh) * 2019-09-18 2021-03-19 大连兆晶生物科技有限公司 一种简易成分鉴定的方法
CA3229844A1 (en) * 2021-08-27 2023-03-02 Matthew James CLEMENTE Systems and methods for determining and communicating levels of bilirubin and other subcutaneous substances

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5777793A (en) * 1996-07-25 1998-07-07 Northern Telecom Limited Polarization insensitive multilayer planar reflection filters with near ideal spectral response

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4985737A (en) * 1988-11-16 1991-01-15 Georgia Tech Research Corporation Solid state quantum mechanical electron and hole wave devices
CN1051825A (zh) * 1989-11-14 1991-05-29 乔治亚州技术研究所 固态、量子力学电子和空穴波器件
US5353790A (en) 1992-01-17 1994-10-11 Board Of Regents, The University Of Texas System Method and apparatus for optical measurement of bilirubin in tissue
US6172743B1 (en) 1992-10-07 2001-01-09 Chemtrix, Inc. Technique for measuring a blood analyte by non-invasive spectrometry in living tissue
US5477326A (en) 1994-06-30 1995-12-19 Bayer Corporation Spectrophotometer arrangement with multi-detector readhead
AU5665996A (en) 1995-05-16 1996-11-29 Afmc Lo/Jaz System and method for enhanced visualization of subcutaneous structures
US6882873B2 (en) 1996-01-17 2005-04-19 Respironics, Inc. Method and system for determining bilirubin concentration
US6040578A (en) 1996-02-02 2000-03-21 Instrumentation Metrics, Inc. Method and apparatus for multi-spectral analysis of organic blood analytes in noninvasive infrared spectroscopy
GB2328279B (en) * 1997-08-12 2001-10-10 Abbott Lab Optical glucose detector
GB9901858D0 (en) * 1999-01-29 1999-03-17 Secr Defence Optical filters
JP3303831B2 (ja) 1999-03-31 2002-07-22 ミノルタ株式会社 経皮的ビリルビン濃度測定装置およびこの測定装置に用いる測定データ検査板
FR2806609B1 (fr) * 2000-03-24 2002-10-11 Medick S A Procede et dispositif de mesure non invasive d'un tissu et notamment du taux de bilirubine de la peau
RU2257144C2 (ru) 2003-09-30 2005-07-27 Закрытое акционерное общество Научно-производственное предприятие "ТЕХНОМЕДИКА" Устройство для определения содержания билирубина в подкожных тканях и крови пациентов
KR20080106244A (ko) * 2006-02-13 2008-12-04 올 프로텍트 엘엘씨 제 3 자에게 주어진 차량을 제어하는 시스템
WO2008110968A1 (en) * 2007-03-12 2008-09-18 Koninklijke Philips Electronics N.V. A system, computer-readable medium, method, and use for combined epithelial early cancer diagnosis and staging
US8849380B2 (en) 2007-11-26 2014-09-30 Canfield Scientific Inc. Multi-spectral tissue imaging

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5777793A (en) * 1996-07-25 1998-07-07 Northern Telecom Limited Polarization insensitive multilayer planar reflection filters with near ideal spectral response

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2011148280A1 *

Also Published As

Publication number Publication date
CN102906559B (zh) 2016-06-22
US9279763B2 (en) 2016-03-08
US20130057865A1 (en) 2013-03-07
WO2011148280A1 (en) 2011-12-01
CN102906559A (zh) 2013-01-30

Similar Documents

Publication Publication Date Title
US9279763B2 (en) Apparatus and method for measuring an analyte such as bilirubin, using light
US9265457B2 (en) Apparatus and method for measuring a tissue analyte such as bilirubin using the Brewster's angle
US7319894B2 (en) Continuous spectroscopic measurement of total hemoglobin
KR100376649B1 (ko) 저포화도에대해최적화된산소포화도측정기및센서
CA2605467C (en) Systems and methods for correcting optical reflectance measurements
US20030144584A1 (en) Pulse oximeter and method of operation
US20080132771A1 (en) Measurement of blood oxygen saturation
US20050203357A1 (en) Pulse oximetry motion artifact rejection using near infrared absorption by water
US20130310668A1 (en) System, method and computer program product for optical measurement of blood parameters
US20150313541A1 (en) Method and apparatus for determining tissue hydration
KR20150005700A (ko) 로버스트 캘리브레이션 및 자가-수정을 위한 조직 옥시메트리 프로브 기하학
KR101097399B1 (ko) 피부 자가형광을 이용한 최종 당화 산물 양의 평가에 의한 질병 진단 장치
KR102002589B1 (ko) 주파수 도메인 기반의 다파장 생체신호 분석 장치 및 그 방법
US20080081966A1 (en) Symmetric LED array for pulse oximetry
US20100076319A1 (en) Pathlength-Corrected Medical Spectroscopy
CN111434309A (zh) 用于新生儿黄疸监测和管理的传感器和系统
JP2019505275A (ja) 血液中に存在する化合物の濃度を測定するための装置及び方法
KR101454298B1 (ko) 반사광 검출용 피라미드형 피부 형광 측정 장치
WO2016108056A1 (en) A ppg-based physiological sensing system with a spatio-temporal sampling approach towards identifying and removing motion artifacts from optical signals
WO2019208561A1 (ja) 血液成分の血中濃度測定方法、血中濃度測定装置およびプログラム
US20160022147A1 (en) Method and device for monitoring vital functions
CN109890287B (zh) 无创测定血液中血红蛋白浓度和氧浓度的方法
KR101454271B1 (ko) 반사광 검출형 피부 형광 측정 장치
JP2019130070A (ja) 生体情報測定装置
WO2014052040A2 (en) Noninvasive absolute oximetry of brain tissue

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20130102

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: KONINKLIJKE PHILIPS N.V.

17Q First examination report despatched

Effective date: 20180618

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20190910